Buying drugs at the right price won't improve outcomes or reduce cost if we arent buying the right drugs.
Estimate the Impact of MTO on Your Health Plan
Your Health Plan
Health Plan Type
[Plan Type]
Number of Covered Lives
35,000
MTO Impact
3,710
Patients with actionable medication failure risk
3,710
Preventable emergency room visits per year
3,710
Preventable inpatient days per year
Annual medical cost reduction
000,000,000
✱
Estimates based on aggregated DecisionRx patient data, and assume risk-targeted MTO assessments are completed for 20% of the population. For a detailed analysis specific to your plan members, contact Payer.Services@DecisionRx.com.
Addressing “high drug prices” isn’t the most effective approach to managing unsustainable healthcare costs when the cost of avoidable drug failures is a 30 times larger opportunity.
Applied at scale, no other clinical intervention has a greater impact on total healthcare cost than simply optimizing medication therapy for each patient’s individual needs, rather than accepting the trial-and-error prescribing paradigm that results in over 25% of prescriptions being ineffective, unsafe, or both.
Annual Burden of Non-optimized medication therapy in the U.S.
$528B
avoidable healthcare costs
(16% of total spending)
275k
avoidable deaths
The DecisionRx Medication Therapy Optimization (MTO) platform leverages modern clinical and data science to help providers improve outcomes and reduce total healthcare costs by 8-11% (over $300 monthly for patients over age 65 and $100 for patients under 65). Cost savings from our value-based MTO program result from:
Risk stratification to focus resources on patients most likely to benefit from an MTO intervention.
Personalized pharmacist recommendations of patient genetics and clinical history.
Increased medication adherence due to reduced undesirable side effects.
Improved patient health literacy and care coordination.